top of page
DNA
APC | MSH6 | ARID1A | MYC | BRAF | NRAS | CDKN2A | PIK3CA | CTNNB1 | PMS2 | ERBB2 | ERBB3 |
PTEN | FBXW7 | RNF43 | GNAS | SMAD4 | KRAS | SOX9 | MLH1 | TCF7L2 | MSH2 | TP53 | POLE |
FUSION
ALK Fusion | NTRK1 Fusion | NTRK2 Fusion | NTRK3 Fusion | PD-L1 IHC |
Method: Next Generation Sequencing (NGS)
Sample Type: Tissue, Blood (Liquid Biopsy Tube)
Result Time: 20-25 Days
Sensitivity: 99%
Description: 24 Genes - 4 Fusions + PD-L1 IHC
PANKREAS PLUS PANELİ
✓ Paraffin Block ✓ Liquid Biopsy
PANKREAS PLUS PANELİ
Treatment options are needed in pancreatic cancer, which is one of the rare types. For this reason, it is recommended to perform comprehensive genetic analyzes, especially KRAS and BRCA mutation.
bottom of page